Cargando…

Belinostat for Relapsed or Refractory Peripheral T-Cell Lymphoma

Detalles Bibliográficos
Autores principales: Hood, Katelyn, Shah, Arpita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5226312/
https://www.ncbi.nlm.nih.gov/pubmed/28090369
_version_ 1782493634714664960
author Hood, Katelyn
Shah, Arpita
author_facet Hood, Katelyn
Shah, Arpita
author_sort Hood, Katelyn
collection PubMed
description
format Online
Article
Text
id pubmed-5226312
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Harborside Press
record_format MEDLINE/PubMed
spelling pubmed-52263122017-01-15 Belinostat for Relapsed or Refractory Peripheral T-Cell Lymphoma Hood, Katelyn Shah, Arpita J Adv Pract Oncol Review Article Harborside Press 2016-03 2016-03-01 /pmc/articles/PMC5226312/ /pubmed/28090369 Text en Copyright © 2016, Harborside Press http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited and is for non-commercial purposes.
spellingShingle Review Article
Hood, Katelyn
Shah, Arpita
Belinostat for Relapsed or Refractory Peripheral T-Cell Lymphoma
title Belinostat for Relapsed or Refractory Peripheral T-Cell Lymphoma
title_full Belinostat for Relapsed or Refractory Peripheral T-Cell Lymphoma
title_fullStr Belinostat for Relapsed or Refractory Peripheral T-Cell Lymphoma
title_full_unstemmed Belinostat for Relapsed or Refractory Peripheral T-Cell Lymphoma
title_short Belinostat for Relapsed or Refractory Peripheral T-Cell Lymphoma
title_sort belinostat for relapsed or refractory peripheral t-cell lymphoma
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5226312/
https://www.ncbi.nlm.nih.gov/pubmed/28090369
work_keys_str_mv AT hoodkatelyn belinostatforrelapsedorrefractoryperipheraltcelllymphoma
AT shaharpita belinostatforrelapsedorrefractoryperipheraltcelllymphoma